M Zierski. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Antitubercular Agents/administration & dosageDrug Resistance, MicrobialEthambutol/administration & dosageHumansIsoniazid/administration & dosageLong-Term CareMethodsRifampin/administration & dosageStreptomycin/administration & dosageTuberculosis, Pulmonary/drug therapy
Substances: See more » Antitubercular AgentsEthambutolIsoniazidRifampinStreptomycin
Year: 1972 PMID: 4624643 DOI: 10.1007/bf02101137
Source DB: PubMed Journal: Pneumonologie ISSN: 0033-4073